Am J Epidemiol

1. AKWIWU EU, Klausch T, Jodal HC, Carvalho B, et al
   Fitting a progressive three-state colorectal cancer model to interval-censored surveillance data under outcome-dependent sampling using a weighted likelihood approach.
   Am J Epidemiol. 2024 Aug 30:kwae307. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Surg

2. RAJE P, Sonal S, Kunitake H, Berger DL, et al
   Comparison of conventional resection to D3 lymphadenectomy in right-sided colon cancer: A retrospective cohort study.
   Am J Surg. 2024;237:115911.
   

   >> Share

   
   

   
   Ann Oncol

3. CIARDIELLO D, Bielo LB, Napolitano S, Martinelli E, et al
   Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF(V600E) wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
   Ann Oncol. 2024 Aug 28:S0923-7534(24)03914-0. doi: 10.1016/j.annonc.2024.08.2334
   

   >> Share

   
   

   
   Ann Surg

4. DAGENBORG VJ, Brudvik KW, Lund-Andersen C, Torgunrud A, et al
   Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.
   Ann Surg. 2024 Aug 26. doi: 10.1097/SLA.0000000000006492.
   

   >> Share

   
   

   
   Anticancer Res

5. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
   Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
   Anticancer Res. 2024;44:3945-3954.
   

   >> Share

   
   
6. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
   Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
   Anticancer Res. 2024;44:4019-4029.
   

   >> Share

   
   
7. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
   Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
   Anticancer Res. 2024;44:3899-3906.
   

   >> Share

   
   
8. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
   Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
   Anticancer Res. 2024;44:3757-3769.
   

   >> Share

   
   
9. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
   The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
   Anticancer Res. 2024;44:3955-3964.
   

   >> Share

   
   
10. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
    Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
    Anticancer Res. 2024;44:4073-4083.
    

    >> Share

    
    
11. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
    Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
    Anticancer Res. 2024;44:4119-4125.
    

    >> Share

    
    

    
    BMC Cancer

12. NOBIN H, Garvin S, Hagman H, Nodin B, et al
    The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types.
    BMC Cancer. 2024;24:1051.
    

    >> Share

    
    
13. FENG Y, Wang K, Fan J, Wu X, et al
    Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study.
    BMC Cancer. 2024;24:1055.
    

    >> Share

    
    
14. WANG Y, Wei Y, Huang J, Li X, et al
    Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    BMC Cancer. 2024;24:1065.
    

    >> Share

    
    

    
    Br J Cancer

15. GWENZI T, Schrotz-King P, Anker SC, Schottker B, et al
    Prognostic value of post-operative iron biomarkers in colorectal cancer: population-based patient cohort.
    Br J Cancer. 2024 Aug 27. doi: 10.1038/s41416-024-02814.
    

    >> Share

    
    

    
    Br J Surg

16. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    

    >> Share

    
    
17. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    

    >> Share

    
    
18. DONNELLY M, Ryan OK, Ryan EJ, Winter DC, et al
    Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae211.
    

    >> Share

    
    

    
    Cancer Treat Res

19. VITELLO DJ, Merkow RP
    The Use of Hepatic Artery Infusion Chemotherapy for Unresectable Colorectal Cancer Liver Metastases.
    Cancer Treat Res. 2024;192:265-276.
    

    >> Share

    
    
20. SHARMA K, Sundling KE, Zhang R, Matkowskyj KA, et al
    Pathologic Features of Primary Colon, Rectal, and Anal Malignancies.
    Cancer Treat Res. 2024;192:233-263.
    

    >> Share

    
    

    
    Eur J Surg Oncol

21. TRINIDAD-GUTIERREZ I, Vazquez-Borrego MC, Aguilera-Fernandez E, Velez-Castano JE, et al
    Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I.
    Eur J Surg Oncol. 2024;50:108642.
    

    >> Share

    
    

    
    Gastroenterology

22. VAN WIFFEREN F, Greuter MJE, van Leerdam ME, Spanier MBW, et al
    Combining colonoscopy with FIT can improve current familial colorectal cancer colonoscopy surveillance - a modelling study.
    Gastroenterology. 2024 Aug 28:S0016-5085(24)05405.
    

    >> Share

    
    

    
    Gastrointest Endosc

23. GRIMALDI J, Masgnaux LJ, Lafeuille P, de Cristofaro E, et al
    Endoscopic submucosal dissection with adaptive traction strategy: first prospective multicenter study (with video).
    Gastrointest Endosc. 2024;100:517-523.
    

    >> Share

    
    
24. KHALAF K, Seleq S, Bourke MJ, Alkandari A, et al
    Establishment of standards for the referral of large nonpedunculated colorectal polyps: an international expert consensus using a modified Delphi process.
    Gastrointest Endosc. 2024;100:510-516.
    

    >> Share

    
    
25. TATE DJ, Vosko S, Bar-Yishay I, Desomer L, et al
    Incomplete mucosal layer excision during EMR: a potential source of recurrent adenoma (with video).
    Gastrointest Endosc. 2024;100:501-509.
    

    >> Share

    
    
26. REX DK, Anderson JC, Butterly LF, Day LW, et al
    Quality indicators for colonoscopy.
    Gastrointest Endosc. 2024;100:352-381.
    

    >> Share

    
    
27. MA B, Meng Q
    Watch and wait or endoscopic hemostasis: delayed bleeding after colorectal endoscopic submucosal dissection.
    Gastrointest Endosc. 2024;100:581.
    

    >> Share

    
    

    
    Int J Cancer

28. STERPETTI AV, Borrelli V, Sapienza P, Campagnol M, et al
    Comments on "Differences in survival and recurrence of colorectal cancer by stage across population-based European registries".
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35150.
    

    >> Share

    
    

    
    J Clin Oncol

29. LU J, Xing J, Zang L, Zhang C, et al
    Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial.
    J Clin Oncol. 2024 Aug 27:JCO2400393. doi: 10.1200/JCO.24.00393.
    

    >> Share

    
    
30. TAKASHIMA A, Hamaguchi T, Mizusawa J, Nagashima F, et al
    Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).
    J Clin Oncol. 2024 Aug 26:JCO2302722. doi: 10.1200/JCO.23.02722.
    

    >> Share

    
    

    
    J Natl Cancer Inst

31. CHENG E, Ou FS, Gatten C, Ma C, et al
    Plant-Based Diet and Survival Among Patients with Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2024 Aug 30:djae213. doi: 10.1093.
    

    >> Share

    
    
32. BROWN JC, Ma C, Shi Q, Couture F, et al
    Inflammation, Physical Activity, and Disease-Free Survival in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
    J Natl Cancer Inst. 2024 Aug 24:djae203. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS One

33. ALMUTAIRI MH, Alrubie TM, Alshareeda AT, Albarakati N, et al
    Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs.
    PLoS One. 2024;19:e0307724.
    

    >> Share

    
    
34. NG AP, Kim S, Chervu N, Gao Z, et al
    Disparities in outcomes of colorectal cancer surgery among adults with intellectual and developmental disabilities.
    PLoS One. 2024;19:e0308938.
    

    >> Share

    
    
35. ZHANG M, Li W, Zhao Y, Qi L, et al
    Molecular characterization analysis of PANoptosis-related genes in colorectal cancer based on bioinformatic analysis.
    PLoS One. 2024;19:e0307651.
    

    >> Share

    
    
36. BALTA B, Taylor L, Bogale N, Hailu D, et al
    Survival and predictors of mortality among colorectal cancer patients on follow-up in Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia, 2022. A 5-year retrospective cohort study.
    PLoS One. 2024;19:e0304820.
    

    >> Share

    
    

    
    World J Surg

37. OSSEIS M, Habib FA, Al Rachid M, El Hadi C, et al
    The impact of economic crisis, COVID-19, and the Beirut Blast on colorectal cancer patients in Lebanon: A trend to operate more late-stage complex cases.
    World J Surg. 2024 Aug 25. doi: 10.1002/wjs.12321.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share